±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1439  |  »Ø¸´: 4
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

ÑîÎÄËÉ˧

ľ³æ (ÕýʽдÊÖ)

[ÇóÖú] Reference StandardÔÚFDAÖÐÊÇʲôÒâ˼£¿¶Ô±ÈRLDÓÐÊ²Ã´Çø±ð ÒÑÓÐ1È˲ÎÓë

FDAÖÐReference StandardºÍReference Listed Drug¸÷ÓÐÊ²Ã´Çø±ð£¿

Reference StandardÔÚFDAÖÐÊÇʲôÒâ˼£¿¶Ô±ÈRLDÓÐÊ²Ã´Çø±ð
U{@U@H2D62L5W}4VFGFMBJS.png
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

Ö»ÊDzÁÉË
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÑîÎÄËÉ˧

ľ³æ (ÕýʽдÊÖ)

Ëͺ컨һ¶ä
ÒýÓûØÌû:
2Â¥: Originally posted by zhangxuan200 at 2017-02-04 16:07:55
A ¡°reference standard¡± is the drug product selected by FDA that an applicant seeking approval of  an ANDA must use in conducting an in vivo bioequivalence study required for approval of the ANDA. T ...

лл£¬Ö»ÊÇÎÒ»¹ÊÇÓÐЩ²»Ã÷°×¡£FDAÖиÃÒ©Æ·ÓÐËÄÖÖ¹æ¸ñ£¬²¢ÇÒRLD¾ù±êΪÁËYES£¬ÇÒÖ»ÔÚ×î´ó¼ÁÁ¿µÄ200mgµÄreference standard±êÁËYES£¬ÊDz»ÊÇÆäËûµÄ¹æ¸ñÒ²¿ÉÒÔ×÷Ϊ²Î±ÈÖÆ¼Á£¿
Ö»ÊDzÁÉË
3Â¥2017-02-04 16:23:02
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 5 ¸ö»Ø´ð

zhangxuan200

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÑîÎÄËÉ˧: ½ð±Ò+10, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2017-02-04 16:18:29
A ¡°reference standard¡± is the drug product selected by FDA that an applicant seeking approval of  an ANDA must use in conducting an in vivo bioequivalence study required for approval of the ANDA. To facilitate generic drug development, FDA generally selects a single reference  standard that ANDA applicants must use in any in vivo testing conducted to support a demonstration of bioequivalence. FDA selects a single reference standard to ensure the greatest  level of consistency between a generic drug and its RLD and among generic drugs. Ordinarily,  the reference standard selected by FDA will be the RLD. FDA usually selects as the reference standard the highest strength available for drug products with multiple approved strengths.

reference standardÓ¦¸ÃÊÇ×÷ΪBE±ØÐëÓõIJαÈÖÆ¼ÁµÄÒâ˼£¨Ò»°ãµÄreference standard¾ÍÊÇRLD£©

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

2Â¥2017-02-04 16:07:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhangxuan200

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

ÒýÓûØÌû:
3Â¥: Originally posted by ÑîÎÄËÉ˧ at 2017-02-04 16:23:02
лл£¬Ö»ÊÇÎÒ»¹ÊÇÓÐЩ²»Ã÷°×¡£FDAÖиÃÒ©Æ·ÓÐËÄÖÖ¹æ¸ñ£¬²¢ÇÒRLD¾ù±êΪÁËYES£¬ÇÒÖ»ÔÚ×î´ó¼ÁÁ¿µÄ200mgµÄreference standard±êÁËYES£¬ÊDz»ÊÇÆäËûµÄ¹æ¸ñÒ²¿ÉÒÔ×÷Ϊ²Î±ÈÖÆ¼Á£¿...

¼ûÕâ¸öÖ¸µ¼Ô­Ôò£¬¸Õ³öµÄ¡°Referencing Approved Drug Products in ANDA Submissions.¡±
4Â¥2017-02-04 16:41:34
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhangxuan200

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

5Â¥2017-02-04 16:42:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 311Çóµ÷¼ÁÒ»Ö¾Ô¸ºÏ·Ê¹¤Òµ´óѧ +6 Çï¶þÊ®¶þ 2026-03-30 6/300 2026-03-31 10:24 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] Ò»Ö¾Ô¸±±»¯085600²ÄÁÏר˶275|ÓÐÎÄÕÂרÀû£üÇóµ÷¼Á +14 Micky11223 2026-03-25 15/750 2026-03-31 10:12 by cal0306
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤µ÷¼Á +16 kikiki7 2026-03-30 16/800 2026-03-31 10:03 by ÂÈ»¯ÑÇÏõõ£
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷½»288»¯¹¤×¨Ë¶Çóµ÷¼Á +4 ºÃÔ˺ÃÔË½Ó½Ó 2026-03-24 4/200 2026-03-31 09:18 by Î÷¾©Ñ§ÔºÍÁľ¹¤³
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤µ÷¼ÁÒ»Ö¾Ô¸´óÁ¬º£ÊÂ085600£¬349 +6 ³ÔµÄ²»ÉÙ 2026-03-30 6/300 2026-03-31 04:17 by fmesaito
[¿¼ÑÐ] 11408×Ü·Ö309£¬Ò»Ö¾Ô¸¶«ÄÏ´óѧÇóµ÷¼Á£¬²»Ìôרҵ +5 Ì츳´øµ½THU 2026-03-29 6/300 2026-03-30 20:49 by dick_runner
[¿¼ÑÐ] 286·Öµ÷¼Á +10 Faune 2026-03-30 11/550 2026-03-30 20:35 by °¡Àî999
[¿¼ÑÐ] 0703Ò»Ö¾Ô¸9£¬³õÊԳɼ¨£º338£¬ËÄÁù¼¶Òѹý£¬ÓпÆÑо­Àú£¬Çóµ÷¼Á£¡ +7 Zuhui0306 2026-03-25 7/350 2026-03-30 19:01 by Ô´_2020
[¿¼ÑÐ] Çóµ÷¼Á +10 ¼Ò¼Ñ¼Ñ¼Ñ¼Ñ¼Ñ 2026-03-29 10/500 2026-03-30 18:34 by 544594351
[¿¼ÑÐ] Çó»¯Ñ§µ÷¼Á +11 wulanna 2026-03-28 11/550 2026-03-30 10:59 by ̽123
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +6 @taotao 2026-03-26 7/350 2026-03-30 10:43 by ÎÒÊÇС¿µ
[¿¼ÑÐ] 317Çóµ÷¼Á +10 µ°»ÆÏÌÈâôÕ 2026-03-26 10/500 2026-03-30 09:45 by longlotian
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬335·Ö£¬0856£¬Çóµ÷¼ÁԺУºÍµ¼Ê¦ +7 Çã____Ïô 2026-03-27 8/400 2026-03-30 09:37 by longlotian
[¿¼ÑÐ] 343Çóµ÷¼Á085601 +3 ҪŬÁ¦Ñ§Ï°x 2026-03-29 3/150 2026-03-29 18:35 by wxiongid
[¿¼ÑÐ] 343Çóµ÷¼Á +6 °®î¿°í 2026-03-29 6/300 2026-03-29 12:00 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 283Çóµ÷¼Á +7 A child 2026-03-28 7/350 2026-03-28 12:05 by zllcz
[¿¼ÑÐ] 309Çóµ÷¼Á +4 gajsj 2026-03-25 5/250 2026-03-26 00:27 by Dyhoer
[¿¼ÑÐ] 334·Ö Ò»Ö¾Ô¸ÎäÀí-080500 ²ÄÁÏÇóµ÷¼Á +4 ÀîÀî²»·þÊä 2026-03-25 4/200 2026-03-25 21:26 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] »úеѧ˶×Ü·Ö317Çóµ÷¼Á£¡£¡£¡£¡ +4 Acaciad 2026-03-25 4/200 2026-03-25 19:59 by hanserlol
[¿¼ÑÐ] µ÷¼Á +4 13853210211 2026-03-24 4/200 2026-03-24 19:44 by ms629
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û